Max Robotics — Global Service Robot Directory + US Certification

About

Teppei Morikawa is a urologic surgeon and researcher advancing the frontiers of surgical oncology for bladder and kidney cancers. His work centers on optimizing perioperative care and refining surgical techniques to improve patient outcomes. Dr. Morikawa’s most impactful contribution is his 2023 study on enhanced recovery after surgery (ERAS) protocols in robot-assisted radical cystectomy (RARC), which has garnered 9 citations and demonstrates how structured perioperative pathways can reduce recovery times and complications for muscle-invasive bladder cancer patients. He has also made significant strides in nephron-sparing surgery, with his 2021 investigation into off-clamp open partial nephrectomy without renorrhaphy for ≥T1b renal tumors (7 citations) challenging conventional methods to preserve kidney function. Additionally, his clinical acumen is highlighted in a 2023 case report documenting an asymptomatic renal granuloma arising three years after intravesical BCG therapy for bladder cancer—a rare complication that adds valuable insight to the literature. Through these studies, Morikawa is shaping evidence-based urologic practice, balancing aggressive oncologic control with meticulous preservation of quality of life.